CIK 0001515673 · Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272546083
- Phone
- 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Fust Matthew K Director | Grant or award | +5,740 | 25,945 | ||
| 2025-05-15 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +10,787 | 10,787 | ||
| 2025-05-15 | Dunsire Deborah Director | Grant or award | +5,740 | 30,815 | ||
| 2025-05-15 | Dunsire Deborah Director | Grant or award · Stock Option (Right to Buy) | +10,787 | 10,787 | ||
| 2025-05-15 | Ray Amrit Director | Grant or award | +5,740 | 23,365 | ||
| 2025-05-15 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +10,787 | 10,787 | ||
| 2025-05-05 | Crombez Eric EVP and Chief Medical Officer | Sale | −520 | $39.24 | $20K | 71,530 |
| 2025-04-21 | Crombez Eric EVP and Chief Medical Officer | Sale | −242 | $35.11 | $8K | 71,680 |
| 2025-03-06 | Horn Howard Chief Financial Officer | Sale | −1,785 | $40.40 | $72K | 106,169 |
| 2025-03-03 | Kassberg Thomas Richard CBO & EVP | Sale | −6,028 | $42.10 | $254K | 265,238 |
| 2025-03-03 | Kassberg Thomas Richard CBO & EVP | Shares withheld for taxes | −508 | $42.92 | $22K | 264,730 |
| 2025-03-03 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | −12,846 | $42.10 | $541K | 75,287 |
| 2025-03-03 | Crombez Eric EVP and Chief Medical Officer | Sale | −8,945 | $42.10 | $377K | 71,922 |
| 2025-03-03 | Pinion John Richard See Remarks | Sale | −14,439 | $42.10 | $608K | 107,766 |
| 2025-03-03 | Pinion John Richard See Remarks | Shares withheld for taxes | −31 | $42.92 | $1K | 108,428 |
| 2025-03-03 | KAKKIS EMIL D President & CEO | Sale 10b5-1 | −73,434 | $42.10 | $3.1M | 641,731 |
| 2025-03-03 | Harris Erik EVP & Chief Commercial Officer | Sale | −15,103 | $42.10 | $636K | 87,855 |
| 2025-03-03 | Huang Dennis Karl See Remarks | Shares withheld for taxes | −1,348 | $42.92 | $58K | 114,591 |
| 2025-03-03 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | −967 | $42.10 | $41K | 50,265 |
| 2025-03-03 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Shares withheld for taxes | −141 | $42.92 | $6K | 50,124 |
Page 5 of 11 · 204 trades